Table 1 Pathological characteristics of tumors in two groups
Pathological characteristics | Group A n = 88 (69.8%) | Group B n = 38 (30.1%) | p value |
|---|---|---|---|
Tumor size | p = .012 | ||
pT1 | 10 (11.3%) | 12 (31.5%) | |
pT2 | 76 (86.3%) | 24 (63.1%) | |
pT3 | 2 (2.2%) | 2 (5.2%) | |
Histological type | p = .025 | ||
IDC | 76 (86.4%) | 27 (71.1%) | |
ILC | 1 (1.1%) | 4 (10.5%) | |
Others | 11 (12.5%) | 7 (18.4%) | |
Molecular subtype | p = .007 | ||
Luminal A | 7 (8%) | 10 (26.3%) | |
Luminal B | 36 (40.9%) | 16 (42.1%) | |
Her 2 enriched | 19 (21.6%) | 9 (23.7%) | |
Triple negative | 26 (29.5%) | 3 (7.9%) | |
Tumor grade | p < .001 | ||
G1 | 8 (9.1%) | 11 (28.9%) | |
G2 | 25 (28.4%) | 22 (57.9%) | |
G3 | 55 (62.5%) | 5 (13.2%) | |
Ki 67 index | p < .001 | ||
Low (</= 14%) | 8 (9.1%) | 13 (34.2%) | |
High (> 14%) | 80 (9.9%) | 25 (65.8%) | |
LVI | p = .028 | ||
Present | 64 (72.7%) | 20 (52.6%) | |
Absent | 24 (27.3%) | 18 (47.4%) | |
Nodal stage | p = .123 | ||
pN0 | 38 (43.1%) | 26 (68.4%) | |
pN1 | 35 (39.7%) | 9 (23.6%) | |
pN2 | 7 (7.9%) | 2 (5.2%) | |
pN3 | 8 (9%) | 1 (2.6%) |